Innovation Pharmaceuticals Inc (IPIX)

[F1ash]

Would you agree they have the preliminary data based on the following? Why bother to list what types of cancer would be good targets if the drug is not working? I think our goals might be the same. Congratulate yourself on not letting the fact that your account fluctuated by a quarter million dollars bother you. My goal is to share DD with others to help them understand what they own to the fullest extent possible so the daily fluctuations will not cause them unjustifiable doubt.



"With that in mind, we are analyzing the collective preliminary data from the trial to date showing a strong safety profile for Kevetrin, an effect on p53 and data seeming to indicate that ovarian, pancreatic and other FDA designated orphan cancers would be ideal mid-stage clinical trial targets as we plan to move forward. Considering what has been shown recently in the Kevetrin trial and the recently completed Phase 2b trial of Brilacidin for ABSSSI, we believe that we have an incredibly strong franchise headlined by one of the most promising cancer drugs and one of the best antibiotics in development today.”